Efficacy and safety of short-course radiotherapy versus total neoadjuvant therapy in older rectal cancer patients: a randomised pragmatic trial (SHAPERS)
Saúde-Conde, R., Vandamme, T., De Backer, M., Martinive, P., Covas, A., Deleporte, A., Dermine, A., Forget, F., Geboes, K., Gilliaux, Q., Gokburun, Y., Gonne, E., Joye, I., Lecomte, S., Liberale, G., Lybaert, W., Moretti, L., Mortier, L., Mupingu Mwanawa, S., Puleo, F., Saad, E.D., Sinapi, I., Annemans, L., Buyse, M., Sclafani, F.
Published in ESMO Gastrointestinal Oncology (01.06.2024)
Published in ESMO Gastrointestinal Oncology (01.06.2024)
Get full text
Journal Article
599P R-IMMUNE: A phase Ib/II study to evaluate safety and efficacy of atezolizumab combined with radio-chemotherapy in a preoperative setting for patients with locally advanced rectal cancer (LARC)
Carrasco, J., Beniuga, G., Jouret-Mourin, A., Baldin, P., Sinapi, I., Schroeder, D., De Cuyper, A., Sclafani, F., Hendlisz, A., van Laethem, J-L., Boulanger, A-S., Van Ooteghem, G., Dermine, A., Delmarcelle, S., Huyghe, N., Bar, I., van den Eynde, M.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article